{"id":"W3102925784","doi":"10.1136/ijgc-2020-igcs.17","title":"17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; McGill University","funders":"","keywords":"Medicine; Population; Adverse effect; Placebo; Clinical endpoint; Internal medicine; Oncology; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002498625,0.0006662136,0.001847326,0.0002382024,0.0002621223,0.001224427,0.000447865,0.0009425117,0.003376542],"category_scores_gemma":[0.002904711,0.0002544888,0.003658516,0.0004363993,0.0004855287,0.0007548105,0.0003359509,0.002942678,0.0005882885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005500132,"about_ca_system_score_gemma":0.0005769298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003313762,"about_ca_topic_score_gemma":0.0008691819,"domain_scores_codex":[0.9989381,0.0006559469,0.00007748283,0.0001213869,0.00008786338,0.000119095],"domain_scores_gemma":[0.9985462,0.0006009818,0.000473653,0.0001192692,0.00007118579,0.0001887077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8405972,0.001576083,0.03275356,0.003360626,0.01471765,0.0004541196,0.00009501025,0.003191694,0.004963474,0.001032981,0.00849993,0.0887577],"study_design_scores_gemma":[0.6087179,0.1390907,0.1819739,0.001189931,0.02541985,0.001610923,0.0002132427,0.00555154,0.004683778,0.006149553,0.02516302,0.0002356899],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9448649,0.03466494,0.0009121813,0.002370789,0.0006170221,0.0005445638,0.006719724,0.0001026657,0.009203196],"genre_scores_gemma":[0.9839906,0.006047389,0.0005865877,0.001605662,0.0004012171,0.0004817899,0.004422877,0.00003190524,0.002432121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003376542,"threshold_uncertainty_score":0.01321417,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04570199330148044,"score_gpt":0.3495164318110275,"score_spread":0.3038144385095471,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}